Amphastar Pharmaceuticals (AMPH) Intangibles (2013 - 2026)

Amphastar Pharmaceuticals' Intangibles history runs 14 years deep, the most recent figure standing at $29.2 million for Q1 2026.

• On a quarterly basis, Intangibles changed 0.0% year-over-year to $29.2 million in Q1 2026; TTM through Mar 2026 was $29.2 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $29.2 million, changed 0.0% from the prior year.
• Intangibles held at $29.2 million in Q1 2026 per AMPH's latest filing, from $29.2 million in the prior quarter.
• Across five years, Intangibles topped out at $29.2 million in Q2 2022 and bottomed at $29.2 million in Q1 2022.
• The 5-year median for Intangibles is $29.2 million (2022), against an average of $29.2 million.
• Across the five-year window, Intangibles declined 0.09% in 2022 and increased 0.09% in 2023, its largest moves.
• Year by year, Intangibles stood at $29.2 million in 2022, then changed by 0.0% to $29.2 million in 2023, then changed by 0.0% to $29.2 million in 2024, then changed by 0.0% to $29.2 million in 2025, then changed by 0.0% to $29.2 million in 2026.
• Per Business Quant, the three latest AMPH Intangibles figures stand at $29.2 million (Q1 2026), $29.2 million (Q4 2025), and $29.2 million (Q3 2025).